China Pushes Back Against Fentanyl Blame Amidst Rising Tariff Tensions with Trump

In a recent development amidst the escalating trade tensions between the United States and China, Beijing has strongly objected to the ongoing characterization of fentanyl as a pivotal issue used by the Trump administration to justify increasing tariffs. This reaction comes in light of the U.S. imposing significant tariff hikes, which have been linked to China's handling of opioid production, particularly the synthetic opioid, fentanyl.

Continue reading